Upload
rosamond-burns
View
221
Download
0
Tags:
Embed Size (px)
Citation preview
Molecular medicine - 2
Example of identifying a monogenic condition by positional cloning
cystic fibrosis caused by mutations in the CF gene
Most common severe autosomal recessive
condition among Caucasians.
About 5% of white Caucasians of European
descent are asymptomatic carriers.
Frequency of 1 / 2,500 affecting approximately
30,000 people
In 1985, CF locus was localized on the long arm of chromosome 7
In 1989, the gene implicated in CF was isolated (Kerem 1989; Riordan 1989; Rommens 1989).
Pathology
Woe to that child which when kissed on the
forehead tastes salty. He is bewitched and soon
must die
CF from gene to product
CF encodes a Cl- channel (is caused by defects in the CF gene which results in either a decrease in its Cl- transport capacity or its level of cell surface expression
CF gene encodes a cystic fibrosis transmembrane conductance regulator
The genetic analysis showed that this gene, which is responsible for this disorder, contains 24 exons spreading over 250 kb of chromosome 7 (7q31) and encodes an mRNA of 6.5 kb.
CFTR – cystic fibrosis transmembrane
conductance regulator
member of ATP binding cassette (ABC) membrane transporter superfamily
2 homologous halves -1480 amino acids longeach half has 6 transmembrane domains (M1-12) &1 nucleotide binding domain (NBD) which are linked bya cytoplasmic regulatory domain (R-domain) that contains
phosphorylation sites
CFTR function
http://www.infobiogen.fr/services/chromcancer/IntroItems/Images/CFTREnglFig2.jpg
epithelial Cl- transport Cl- transport rate determined by activation of CFTR which in turn depends on its state of phosphorylation.
Acts as a regulator of other channels & transporters e.g CFTR mediates cAMP regulation of amiloride sensitive epithelial Na+ channels (EnaCs)
CFTR channel
Minimum channel diameter – 5.3A
Maximum channel diameter - 10-13A
Charge selectivity: R352, cytoplasmic end of M6
Overall structure: Channel with a large
extracellular vestibule which narrows towards the cytoplasmic end where the anion selectivity filter is located.
Channel lining is formed by M1, M3, M6 & M12 segments.
J Biol Chem (2000) vol 275 No 6 pp 3729 by MH Akabas
Regulation of CFTR gating
phosphorylation: necessary to activate the channel. The R domain contains phosphorylation sites for cAMP-dependent protein kinase A (PKA), C (PKC) and type II cGMP dependent protein kinases. CFTR deactivation mediated by phosphatases PP2C & PP2A.
ATP binding & hydrolysis: Opening / closing of channel controlled by ATP binding &
hydrolysis which occurs in the NBD segment. The R domain interacts with NBD & regulates their ATP affinity.
2 processes control Cl- movement
Spectrum of CF mutations that affect function
F508
70% of CF patients show a specific deletion F508 single amino acid (F) deletion in exon 10 which codes for first portion of NBD-1 of the CFTR protein. This leads to misfolding of CFTR in the endoplasmic reticulum(ER). These immature CFTR proteins are then polyubiquinated & targeted for proteosome degradation
Mapping of CFTR
1985 gene for CF linked to enzyme paraoxanase (PON)PON mapped to chromosome 7 and CF mapped to 7q31-32
(random DNA marker D7S15)2 flanking markers established (~2x106bp apart)
proximal MET oncogene and distal D7S8extensive mapping and characterisation around the candidate
region by chromosome walking, chromosome jumping and microdissection (~300kbp cloned)
CFTR candidate region
Mapping of CFTR
2 new markers identified – KM19 and XV2c – which showed strong linkage disequilibrium5’ end of gene locatedBovine equivalent of candidate gene isolated from genomic library7 cDNA libraries screened with human clone. 1 cDNA clone identified. Northern blots show 6.5 kb mRNARest of the gene obtained by screening and PCR1989 CFTR gene eventually isolated by mutation screening
Letter to Dr. Collins. Courtesy of the National Human Genome Research Institute
The spectrum of human diseases
Cystic fibrosis thalassemia
Huntington’s
cancer
<5%
‘Mendelian’ diseases (<5%)
Autosomal dominant inheritance: e.g huntington’s disease
Autosomal codominant inheritance e.g Hb-S sickle cell disease
Autosomal recessive inheritance: e.g cystic fibrosis, thalassemias
X-linked inheritance: e.g Duchenne muscular dystrophy (DMD)
Mapping complex loci
PAF – population attributable factor:
Fraction of the disease that would be eliminated if the
risk factor were removed
High PAF for single gene conditions (>50% for CF)
Low PAF for complex disease (< 5% for Alzheimer’s)
Identifying genes involved in complex diseases
Steps
Perform family, twin or adoption studies - check for genetic component
Segregation analysis- estimate type and frequency of susceptibility alleles
Linkage analysis- map susceptibility loci
Population association- identify candidate region
Identify DNA sequence variants conferring susceptibility
Linkage versus Assocciation
Association studies compare the allele frequency of a polymorphic marker, or a set of markers, in unrelated patients (cases) and healthy controls to identify markers that differ significantly between the two groups.
Used to identify common modest-risk disease variants
Higher density of markers needed
e.g. HapMap uses association data
Linkage analyses search for regions of the genome with a higher-than-expected number of shared alleles among affected individuals within a family.
Used to identify rare high-risk disease alleles
<500 markers needed for initial genome scan
Haplotype analysis• specific combination of 2 or more DNA marker
alleles situated close together on the same chromosome (cis markers)
• SNPs most commonly used markers in haplotypes.
• series of closely linked mutations accumulate over time in the surviving generation derived from a common ancestor.
• powerful genetic tool for identifying ancient genetic relationships.
• Alleles at separate loci that are associated with each other at a frequency that is significantly higher than that expected by chance, are said to be in linkage disequilibrium
Direct versus indirect association analysis.
a, In direct association analysis,all functional variants (red arrows) are catalogued and tested for association with disease. A GeneSNPs image of the CSF2 gene is shown. Genomic features are shown as boxes along the horizontal axis (for example, blue boxes indicate exons). Polymorphisms are shown as vertical bars below the axis, with the length of the line indicating allele frequency and colour indicating context (for example, red indicates coding SNPs that change amino acids). b, For indirect association analysis, all common SNPs are tested for function by assaying a subset of tagSNPs in each gene (yellow arrows), such that all unassayed SNPs (green arrows) are correlated with one or more tagSNPs. Effects at unassayed SNPs (green arrows) would be detected through linkage disequilibrium with tagSNPs. Images adapted from GeneSNPs (http://www.genome.utah.edu/genesnps).
Formation of haplotypes over time
Ancient disease loci are associated with haplotypes
• Start with population genetically isolated for a long time such as Icelanders or Amish
• Collect DNA samples from subgroup with disease• Also collect from equal number of people without
disease• Genotype each individual in subgroups for
haplotypes throughout entire genome• Look for association between haplotype and
disease phenotype• Association represents linkage disequilibrium• If successful, provides high resolution to narrow
parts of chromosomes
Haplotype analysis provides high resolution gene mapping
Genetic heterogeneityMutations at more than one locus cause
same phenotype
e.g. thalassemias – Caused by mutations in
either the or -globin genes.
– Linkage analysis studies therefore always combine data from multiple families
Why is it still so difficult?
Variable expressivity - Expression of a mutant trait differs from person to person
• Phenocopy– Disease phenotype is not caused by any
inherited predisposing mutation – e.g. BRCA1 mutations
• 33% of women who do not carry BRCA1 mutation develop breast cancer by age 55
Incomplete penetrance – when a mutant genotype does not always cause a mutant phenotype• No environmental factor associated with
likelihood of breast cancer• Positional cloning identified BRCA1 as
one gene causing breast cancer.– Only 66% of women who carry BRCA1
mutation develop breast cancer by age 55
• Incomplete penetrance hampers linkage mapping and positional cloning– Solution – exclude all nondisease individuals
form analysis– Requires many more families for study
• Polygenic inheritance– Two or more genes interact in the
expression of phenotype• QTLs, or quantitative trait loci
– Unlimited number of transmission patterns for QTLs» Discrete traits – penetrance may increase with
number of mutant loci» Expressivity may vary with number of loci
– Many other factors complicate analysis» Some mutant genes may have large effect» Mutations at some loci may be recessive while
others are dominant or codominant
Polygenic inheritance
E.g heart attacks or cholesterol levels
Sudden cardiac death (SCD)
Breast cancer
Although a genetic basis for familial BC identified, the causes of sporadic disease still unknown
Sudden cardiac death (SCD)
Mutations in 2 loci account for 20-25% of early onset (<45 years) breast cancer cases due to inherited factors– BRCA1: mutations found in 80-90% of families
with both breast and ovarian cancer– BRCA2: mutations mainly in male breast
cancer families
Common condition – familial or sporadic forms
Alzheimer’s disease
familial AD – mutations in APP, presenilin-1 and 2Sporadic AD – strong association with APO4, Apolipoprotein 4, which
affects age of onset rather than susceptibility
Sudden cardiac death (SCD)
Affects 5% of people >65 years and 20% of people over 80 has familial (early-onset) or sporadic (late-onset) forms, although
pathologically both are similarAetiology of sporadic forms unknown
3 major alleles (APO E2, E3, and E4)
Position
112 158
ApoE2 Cys Cys
ApoE3 Arg Cys
ApoE4 Arg Arg
Epigenetics – differential imprinting
failure to thrive during infancy, hyperphagia and obesity during early childhood, mental retardation, and behavioural problems
molecular defect involves a ~2 Mb imprinted domain at 15q11–q13 that contains both paternally and maternally expressed genes
Prader-Willi syndrome Angelman syndrome
births and characteristics include mental retardation, speech impairment and behavioural abnormalities
AS defect lies within the imprinted domain at 15q11–q13
Genetic causes
70% have a deletion of the PWS/AS region on their paternal chromosome 15
25% have maternal uniparental disomy for chromosome 15 (the individual inherited both chromosomes from the mother, and none from the father)
5% have an imprintingdefect
<1% have a chromosome abnormality including the PWS/AS region
Prader-Willi syndrome Angelman syndrome70% have a deletion of the PWS/AS region on their maternal chromosome 15
7% have paternal uniparental disomy for chromosome 15 (the individual inherited both chromosomes from the father, and none from the mother)
3% have an imprinting defect
11% have a mutation in UBE3A
1% have a chromosome rearrangement
11% have a unknown genetic cause
Reading
HMG3 by T Strachan & AP Read : Chapter 15
AND/OR
Genetics by Hartwell (2e) chapter 11 References on Cystic fibrosis: Science (1989) vol 245 pg 1059 by JM Rommens et al (CF mapping)J. Biol Chem (2000) vol 275 No 6 pp 3729 by MH Akabas (CFTR)
Optional Reading on Molecular medicine Nature (May2004) Vol 429 Insight series• human genomics and medicine pp439 (editorial)• Mapping complex disease loci in whole genome
studies by CS Carlson et al pp446-452